Therapeutic inertia in relapsing-remitting multiple sclerosis

被引：0

作者：

Rodrigues, R. ^{[1
]}

Rocha, R. ^{[2
]}

Bonifacio, G. ^{[3
]}

Ferro, D. ^{[4
]}

Sabenca, F. ^{[5
]}

Goncalves, A. I. ^{[6
]}

Correia, F. ^{[2
]}

Pinheiro, J. ^{[5
]}

Loureiro, J. L. ^{[1
]}

Guerreiro, R. P. ^{[3
]}

Vale, J. ^{[6
]}

Sa, M. J. ^{[4
]}

Costa, A. ^{[4
]}

机构：

[1] Ctr Hosp Entre Douro & Vouga, Santa Maria Feira, Portugal

[2] Hosp Pedro Hispano, Unidade Local Saude Matosinhos, Matosinhos, Portugal

[3] Ctr Hosp Setubal, Setubal, Portugal

[4] Ctr Hosp Univ Sao Joao, Porto, Portugal

[5] Ctr Hosp Vila Nova de Gaia Espinho, Vila Nova De Gaia, Portugal

[6] Hosp Beatriz Angelo, Loures, Portugal

来源：

MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 3_SUPPL期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P0925

引用

页码：557 / 558

页数：2

共 50 条

[41] Intravenous immunoglobulin in relapsing-remitting multiple sclerosis
Achiron, A
Barak, Y
SarovaPinhas, I
Achiron, R
Gabbay, U
Rotstein, Z
Noy, S
INTRAVENOUS IMMUNOGLOBULIN: RESEARCH AND THERAPY, 1996, : 289 - 293
[42] Oral fingolimod for relapsing-remitting multiple sclerosis
Doggrell, Sheila A.
EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (10) : 1777 - 1781
[43] Thalamic neurodegeneration in relapsing-remitting multiple sclerosis
Wylezinska, M
Cifelli, A
Jezzard, P
Palace, J
Alecci, M
Matthews, PM
NEUROLOGY, 2003, 60 (12) : 1949 - 1954
[44] Natalizumab in spinal relapsing-remitting multiple sclerosis
Zecca, C.
Kamm, C.
Riccitelli, G. C.
Heldner, M.
Caporro, M.
Gobbi, C.
JOURNAL OF NEUROLOGY, 2014, 261 : S303 - S303
[45] Postural Control in Relapsing-Remitting Multiple Sclerosis
Cusin, Flavia Salvaterra
Tomaz, Andreza
Gananca, Mauricio Malavasi
Oliveira, Enedina Maria
Falcao Goncalves, Alessandra Billi
Caovilla, Heloisa Helena
INTERNATIONAL ARCHIVES OF OTORHINOLARYNGOLOGY, 2022, 26 (04) : 592 - 604
[46] Disability trajectories in relapsing-remitting multiple sclerosis
Uher, T.
Horakova, D.
Havrdova, E. Kubala
Izquierdo, G.
Eichau, S.
Patti, F.
Prat, A. P.
Girard, M.
Duquette, P.
Grammond, P.
Onofrj, M.
Lugaresi, A. L.
Bergamaschi, R.
Ozakbas, S.
Grand'Maison, F.
Hupperts, R.
Sola, P.
Ferraro, D.
Sa, M. J.
Kalincik, T.
MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 813 - 814
[47] Current management of relapsing-remitting multiple sclerosis
Sedal, L.
Wilson, I. B.
McDonald, E. A.
INTERNAL MEDICINE JOURNAL, 2014, 44 (10) : 950 - 957
[48] Considerations in the treatment of relapsing-remitting multiple sclerosis
Calabresi, PA
NEUROLOGY, 2002, 58 (08) : S10 - S22
[49] Teriflunomide for the treatment of relapsing-remitting multiple sclerosis
Miller, Aaron E.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (02) : 181 - 194
[50] Teriflunomide: A Review in Relapsing-Remitting Multiple Sclerosis
Scott, Lesley J.
DRUGS, 2019, 79 (08) : 875 - 886

← 1 2 3 4 5 →